Metabolic Syndrome (MS) is a complex disorder, characterized by interrelated metabolic abnormalities. Abdominal obesity is considered a trigger for MS, which represents a risk factor for diseases interconnected by the genesis of insulin resistance.
The most recent definition for MS was described by the International Diabetes Federation (IDF) in 2009], featuring MS as an association of factors like: hypertriglyceridemia (plasma triglyceride levels greater than or equal to 150 mg/dL), low plasma levels of HDL cholesterol (less than 40 mg/dL for men and 50 mg/dL for women), increased plasma glucose levels (greater than or equal to 100 mg/dL), type 2 diabetes mellitus diagnosis, and/or elevated systemic arterial blood pressure (greater than or equal to 130/85 mmHg). Such concept can be easily employed as a diagnostic tool in clinical practice to ascertain the patientâs metabolic and cardiovascular risk, which serves as a guide for their treatment.
Effect of Dietetic Intervention in Brazilian Postmenopausal Women with
Metabolic Syndrome: Viviane do Valle Couto Reis, Gabriela Morgado de Oliveira Coelho, Eliane de Abreu Soares and Avany Fernandes Pereira
Last date updated on January, 2021